Clinton, MA, United States of America

Milan Chytil

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 123(Granted Patents)


Location History:

  • Clinton, MA (US) (2007 - 2013)
  • Acton, MA (US) (2017)

Company Filing History:


Years Active: 2007-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Milan Chytil

Introduction

Milan Chytil is a notable inventor based in Clinton, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, he has made strides in developing compounds that address various neurological and psychiatric disorders.

Latest Patents

Among his latest patents, Milan Chytil has developed fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders. These compounds are designed to be useful in treating a variety of neurological and psychiatric disorders. Additionally, he has patented imidazo[1,2-a]pyridine compounds, which are disclosed as useful therapeutic agents. The compounds from this invention may be included in pharmaceutical formulations and utilized in methods of treatment.

Career Highlights

Milan Chytil has worked with prominent companies in the pharmaceutical industry, including Sunovion Pharmaceuticals Inc. and Sepracor, Inc. His work in these organizations has contributed to the advancement of therapeutic solutions for complex health issues.

Collaborations

Milan has collaborated with notable coworkers such as Seth C. Hopkins and Q. Kevin Fang, enhancing the innovative efforts in his projects.

Conclusion

Milan Chytil's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in developing treatments for CNS disorders. His patents and collaborations reflect a commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…